down arrow

Kwality Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE552U01010
  • NSEID:
  • BSEID: 539997
INR
817.95
40.95 (5.27%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.69 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Net Sales
307.17
251.03
456.19
262.01
139.30
166.29
137.49
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
307.17
251.03
456.19
262.01
139.30
166.29
137.49
Raw Material Cost
153.81
113.22
199.31
165.28
91.92
114.06
103.73
Purchase of Finished goods
0.85
0.04
3.80
0.22
0.67
0.13
0.26
(Increase) / Decrease In Stocks
-1.48
-3.20
-2.51
0.09
-5.51
5.25
-2.70
Employee Cost
32.56
29.96
20.15
15.90
11.93
8.56
5.61
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
0.00
0.00
0.00
0.01
18.93
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
55.12
50.86
63.77
51.68
26.10
22.58
0.00
Total Expenditure (Excl Depreciation)
240.86
190.89
284.52
233.17
125.11
150.59
125.83
Operating Profit (PBDIT) excl Other Income
66.31
60.14
171.67
28.84
14.19
15.70
11.66
Other Income
1.83
2.94
3.51
1.59
3.66
0.61
0.80
Operating Profit (PBDIT)
68.14
63.08
175.18
30.43
17.85
16.31
12.46
Interest
10.39
6.02
2.92
2.67
2.50
2.28
2.19
Exceptional Items
-7.10
-16.53
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
50.65
40.53
172.26
27.76
15.35
14.03
10.28
Depreciation
19.56
14.96
10.69
6.49
4.43
3.12
2.98
Profit Before Tax
31.10
25.57
161.57
21.27
10.92
10.91
7.30
Tax
7.48
6.29
41.63
6.38
2.71
3.35
2.87
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
23.62
19.28
119.94
14.89
8.21
7.56
4.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
23.62
19.28
119.94
14.89
8.21
7.56
4.42
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.18
0.09
0.05
0.26
0.11
0.00
0.12
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
23.80
19.37
119.99
15.15
8.32
7.55
4.55
Equity Capital
10.38
10.38
10.38
10.38
10.38
10.38
10.38
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
213.04
189.34
170.77
50.78
35.63
26.92
0.00
Earnings per share (EPS)
22.93
18.66
115.6
14.6
8.02
7.27
4.38
Diluted Earnings per share
22.76
18.16
115.64
14.6
8.02
7.28
4.38
Operating Profit Margin (Excl OI)
21.59%
23.96%
37.63%
11.01%
10.19%
9.44%
8.48%
Gross Profit Margin
16.49%
16.15%
37.76%
10.6%
11.02%
8.44%
7.47%
PAT Margin
7.69%
7.68%
26.29%
5.68%
5.89%
4.55%
3.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 22.36% vs -44.97% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2024 is 22.87% vs -83.86% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 10.26% vs -64.97% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 72.59% vs 106.16% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has fallen from Mar 2023

Compare Annual Results Of Kwality Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
307.17
10,334.77
-10,027.60
-97.03%
Other Operating Income
0.00
0.00
0.00
Total Operating income
307.17
10,334.77
-10,027.60
-97.03%
Raw Material Cost
153.81
1,853.52
-1,699.71
-91.70%
Purchase of Finished goods
0.85
1,409.85
-1,409.00
-99.94%
(Increase) / Decrease In Stocks
-1.48
-53.67
52.19
97.24%
Employee Cost
32.56
2,274.73
-2,242.17
-98.57%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
55.12
2,315.28
-2,260.16
-97.62%
Total Expenditure (Excl Depreciation)
240.86
7,799.71
-7,558.85
-96.91%
Operating Profit (PBDIT) excl Other Income
66.31
2,535.06
-2,468.75
-97.38%
Other Income
1.83
280.86
-279.03
-99.35%
Operating Profit (PBDIT)
68.14
2,815.92
-2,747.78
-97.58%
Interest
10.39
33.53
-23.14
-69.01%
Exceptional Items
-7.10
0.00
-7.10
Gross Profit (PBDT)
50.65
2,782.39
-2,731.74
-98.18%
Depreciation
19.56
398.25
-378.69
-95.09%
Profit Before Tax
31.10
2,384.14
-2,353.04
-98.70%
Tax
7.48
457.58
-450.10
-98.37%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
23.62
1,926.56
-1,902.94
-98.77%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
23.62
1,926.56
-1,902.94
-98.77%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
0.18
-28.87
29.05
100.62%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
23.80
1,912.90
-1,889.10
-98.76%
Equity Capital
10.38
40.06
-29.68
-74.09%
Face Value
10.00
1.00
0.00
Reserves
213.04
9,323.03
-9,109.99
-97.71%
Earnings per share (EPS)
22.93
47.75
-24.82
-51.98%
Diluted Earnings per share
22.76
47.68
-24.92
-52.27%
Operating Profit Margin (Excl OI)
21.59%
24.53%
0.00
-2.94%
Gross Profit Margin
16.49%
26.92%
0.00
-10.43%
PAT Margin
7.69%
18.79%
0.00
-11.10%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 307.17 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 22.36% vs -44.97% in Mar 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 23.80 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 22.87% vs -83.86% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 66.31 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 10.26% vs -64.97% in Mar 2023

Annual - Interest
Interest 10.39 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 72.59% vs 106.16% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.59%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has fallen from Mar 2023